These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12818815)

  • 21. [In vitro activity of clofazimine alone and in combination with amikacin, roxithromycin, rifampicin and rifapentine against Mycobacterium avium-intracellulare].
    Casal Román M; Rodríguez López F; Villalba Montoro R; González Requero AI
    Enferm Infecc Microbiol Clin; 1989 Oct; 7(8):432-5. PubMed ID: 2490859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of Mycobacterium avium complex infection: do the results of in vitro susceptibility tests predict therapeutic outcome in humans?
    Sison JP; Yao Y; Kemper CA; Hamilton JR; Brummer E; Stevens DA; Deresinski SC
    J Infect Dis; 1996 Mar; 173(3):677-83. PubMed ID: 8627032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bacteriostatic and bactericidal study of rifabutine and clofazimine in combination against Mycobacterium avium-intracellulare and Mycobacterium xenopi].
    Gevaudan MJ; Mallet MN; Bollet C; Gulian C; de Micco P
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):585-90. PubMed ID: 2552379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to various drugs].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1991 Jul; 66(7):489-92. PubMed ID: 1890791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and tolerability of clofazimine as salvage therapy for atypical mycobacterial infection in solid organ transplant recipients.
    Cariello PF; Kwak EJ; Abdel-Massih RC; Silveira FP
    Transpl Infect Dis; 2015 Feb; 17(1):111-8. PubMed ID: 25620390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postantibiotic effect of amikacin, rifampin, sparfloxacin, clofazimine and clarithromycin against Mycobacterium avium.
    Horgen L; Legrand E; Rastogi N
    Res Microbiol; 1997 Nov; 148(8):673-81. PubMed ID: 9765852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New trends in the drug therapy of localized and disseminated Mycobacterium avium complex infection.
    Sesin GP; Manzi SF; Pacheco R
    Am J Health Syst Pharm; 1996 Nov; 53(21):2585-90. PubMed ID: 8913387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment and prophylaxis of disseminated Mycobacterium avium complex in HIV-infected individuals.
    Faris MA; Raasch RH; Hopfer RL; Butts JD
    Ann Pharmacother; 1998 May; 32(5):564-73. PubMed ID: 9606478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of antimycobacterial drugs with the anti-Mycobacterium avium complex effects of antimicrobial effectors, reactive oxygen intermediates, reactive nitrogen intermediates, and free fatty acids produced by macrophages.
    Sano K; Tomioka H; Sato K; Sano C; Kawauchi H; Cai S; Shimizu T
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2132-9. PubMed ID: 15155211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [MICs and MBCs of levofloxacin, clarithromycin, and KRM-1648 for Mycobacterium tuberculosis and M. avium complex residing in MONO-MAC-6 human macrophage-like cell and A-549 human type II alveolar epithelial cell lines].
    Sato K; Ogasawara K; Akaki T; Tomioka H
    Kekkaku; 1999 Jul; 74(7):571-7. PubMed ID: 10481412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low serum levels of oral antimycobacterial agents in patients with disseminated Mycobacterium avium complex disease.
    Gordon SM; Horsburgh CR; Peloquin CA; Havlik JA; Metchock B; Heifets L; McGowan JE; Thompson SE
    J Infect Dis; 1993 Dec; 168(6):1559-62. PubMed ID: 8245546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of picolinic acid on the antimicrobial functions of host macrophages against Mycobacterium avium complex.
    Tomioka H; Shimizu T; Tatano Y
    Int J Antimicrob Agents; 2007 Apr; 29(4):460-4. PubMed ID: 17296287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mycobacterium avium complex infection. Pharmacokinetic and pharmacodynamic considerations that may improve clinical outcomes.
    Peloquin CA
    Clin Pharmacokinet; 1997 Feb; 32(2):132-44. PubMed ID: 9068928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of the Chinese traditional medicines "mao-bushi-saishin-to" and "yokuinin" on the antimycobacterial activity of murine macrophages against Mycobacterium avium complex infection].
    Shimizu T; Sano C; Akaki T; Ogasawara K; Sato K; Tomioka H
    Kekkaku; 1999 Sep; 74(9):661-6. PubMed ID: 10535279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term Follow-up of Mycobacterium avium Complex Lung Disease in Patients Treated With Regimens Including Clofazimine and/or Rifampin.
    Jarand J; Davis JP; Cowie RL; Field SK; Fisher DA
    Chest; 2016 May; 149(5):1285-93. PubMed ID: 26513209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Action of clofazimine on the Mycobacterium avium complex.
    Warek U; Falkinham JO
    Res Microbiol; 1996; 147(1-2):43-8. PubMed ID: 8761721
    [No Abstract]   [Full Text] [Related]  

  • 37. Activity of rifabutin, clarithromycin, ethambutol, sparfloxacin and amikacin, alone and in combination, against Mycobacterium avium complex in human macrophages.
    Pellegrin I; Maugein J; Lapeyre C; Barbeau P; Leng B; Pellegrin JL
    J Antimicrob Chemother; 1996 Mar; 37(3):501-10. PubMed ID: 9182107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin.
    Ferro BE; Meletiadis J; Wattenberg M; de Jong A; van Soolingen D; Mouton JW; van Ingen J
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1097-105. PubMed ID: 26643335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pentoxifylline impairs macrophage defense against Mycobacterium avium complex.
    Sathe SS; Tsigler D; Sarai A; Kumar P
    J Infect Dis; 1995 Sep; 172(3):863-6. PubMed ID: 7658084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of Nosiheptide, Griseoviridin, and Etamycin as Potent Anti-Mycobacterial Agents against Mycobacterium avium Complex.
    Hosoda K; Koyama N; Kanamoto A; Tomoda H
    Molecules; 2019 Apr; 24(8):. PubMed ID: 30995807
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.